A Descriptive Study of an Outbreak of Clenbuterol-Containing Heroin

Annals of Emergency Medicine

Volumn 52, Issue 5, 2008, Pages 548-553

  Hoffman, Robert S ^a   Kirrane, Barbara M ^b   Marcus, Steven M ^c  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLENBUTEROL; DIAMORPHINE; LACTIC ACID;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPNEA; EMERGENCY WARD; HEART MUSCLE INJURY; HEART PALPITATION; HEROIN DEPENDENCE; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; HYPOTENSION; INCIDENCE; LABORATORY TEST; NAUSEA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TACHYCARDIA; THORAX PAIN; TREMOR; UNSPECIFIED SIDE EFFECT; URINALYSIS;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; CARDIOMYOPATHIES; CLENBUTEROL; DISEASE OUTBREAKS; DRUG CONTAMINATION; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; MID-ATLANTIC REGION; MIDDLE AGED; POISON CONTROL CENTERS;

EID: 54149096117     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2008.04.026     Document Type: Article

References (25)

1. Hibbs J., Perper J., and Winek C.L. An outbreak of designer drug-related deaths in Pennsylvania. JAMA 265 (1991) 1011-1013
2. Shannon M. Clinical toxicity of cocaine adulterants. Ann Emerg Med 17 (1988) 1243-1247
3. Centers for Disease Control and Prevention. Lead poisoning associated with intravenous-methamphetamine use-Oregon, 1988. MMWR Morb Mortal Wkly Rep 38 (1989) 830-831
4. Weingarten H.L. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): one designer drug and serendipity. J Forensic Sci 33 (1988) 588-595
5. Klatt E.C., Montgomery S., Namiki T., et al. Misrepresentation of stimulant street drugs: a decade of experience in an analysis program. J Toxicol Clin Toxicol 24 (1986) 441-450
6. Hamilton R.J., Perrone J., Hoffman R., et al. A descriptive study of an epidemic of poisoning caused by heroin adulterated with scopolamine. J Toxicol Clin Toxicol 38 (2000) 597-608
7. Centers for Disease Control and Prevention. Atypical reactions associated with heroin use-five states January-April 2005. MMWR Morb Mortal Wkly Rep 54 (2005) 793-796
8. Girault J., Gobin P., and Fourtillan J.B. Quantitative measurement of clenbuterol at the femtomole level in plasma and urine by combined gas chromatography/negative ion chemical ionization mass spectrometry. Biomed Environ Mass Spectrom 19 (1990) 80-88
9. Valente Merida J., and Medina J. Placebo-controlled comparative study of clenbuterol and terbutaline in asthmatic children. Rev Alerg Mex 36 (1989) 61-64
10. Boner A.L., Vallone G., Brighenti C., et al. Comparison of the protective effect and duration of action of orally administered clenbuterol and salbutamol on exercise-induced asthma in children. Pediatr Pulmonol 4 (1988) 197-200
11. Erichsen D.F., Aviad A.D., Schultz R.H., et al. Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD). Equine Vet J 26 (1994) 331-336
12. Brambilla G., Cenci T., Franconi F., et al. Clinical and pharmacological profile in a clenbuterol epidemic poisoning of a contaminated beef meet in Italy. Toxicol Lett 114 (2000) 47-53
13. Dumestre-Toulet V., Cirimele V., Ludes B., et al. Hair analysis of seven bodybuilders for anabolic steroids, ephedrine, and clenbuterol. J Forensic Sci 47 (2002) 211-214
14. Chodorowski Z., and Sein Anand J. Acute poisoning with clenbuterol-a case report. Przegl Lek 54 (1997) 763-764
15. Barbosa J., Cruz C., Martins J., et al. Food poisoning by clenbuterol in Portugal. Food Addit Contam 22 (2005) 563-566
16. Hoffman R.J., Hoffman R.S., Freyberg C.L., et al. Clenbuterol ingestion causing prolonged tachycardia, hypokalemia and hypophosphatemia with confirmation by quantitative levels. J Toxicol Clin Toxicol 39 (2001) 339-344
17. Sherry T., McDonagh J., Johnson-Arbor K., et al. Clenbuterol-adulterated cocaine: a case series. [abstract]. Clin Toxicol 44 (2006) 115
18. Kierzkowska B., Stanczyk J., and Kasprazak D. Myocardial infarction in a 17-year-old bod builder using clenbuterol. Circulation 69 (2005) 1144-1146
19. Goldstein D.R., Dobbs T., Drull B., et al. Clenbuterol and anabolic steroids: a previously unreported cause of myocardial infarction with normal coronary arteriograms. South Med J 91 (1998) 780-784
20. Biberstein M.P., Ziegler M.G., and Ward D.M. Use of beta-blockade and hemoperfusion for acute theophylline poisoning. West J Med 141 (1984) 485-490
21. Gaar G.G.G., Banner Jr. W., and Laddu A.R. The effects of esmolol on the hemodynamics of acute theophylline toxicity. Ann Emerg Med 16 (1987) 1334-1339
22. Price K.R., and Fligner D.J. Treatment of caffeine toxicity with esmolol. Ann Emerg Med 19 (1990) 44-46
23. Hoffman R.S. Cocaine and beta-blockers: should the controversy continue?. Ann Emerg Med 51 (2008) 127-129
24. Maistro S., Chiesa E., Angeletti R., et al. Beta blockers to prevent clenbuterol poisoning. Lancet 346 (1995) 180
25. Dattilo P.B., Hailpern S.M., Fearon K., et al. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med 51 (2008) 117-125